Weight Loss Drug Safety Questioned by FDA

Article

FDA and Industry Officials Disagree Over Ephedra

Questions are being raised as to whether the dietary supplement ephedra is safe and effective or potentially dangerous. The Food & Drug Administration (FDA) recently outlined 100 reports of serious health problems they link to products containing the supplement. The reports, collected for almost two years, include 46 cases of cardiovascular problems-including seven deaths by cardiac arrest-and 41 cases of central-nervous-system problems such as stimulant effects and seizures.

Industry representatives criticized the FDA's data and attribute the reported health problems to underlying conditions, use of multiple products, and excessive fasting and exercise. A medical examiner that reviewed 22 deaths possibly linked to ephedra products said that all but two cases were likely caused by other medical problems.

Because ephedra is a dietary supplement, the FDA must treat it as a food supplement and not as a drug. For more information visit the Food & Drug Administration website at www.fda.gov.

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content